Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients
McInnes, G., Evans, M., Del Prato, S., Stumvoll, M., Schweizer, A., Lukashevich, V., Shao, Q., Kothny, W.
Published in Diabetes, obesity & metabolism (01.11.2015)
Published in Diabetes, obesity & metabolism (01.11.2015)
Get full text
Journal Article
Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17000 patients
McInnes, G, Evans, M, Del Prato, S, Stumvoll, M, Schweizer, A, Lukashevich, V, Shao, Q, Kothny, W
Published in Diabetes, obesity & metabolism (01.11.2015)
Published in Diabetes, obesity & metabolism (01.11.2015)
Get full text
Journal Article
Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population
Schweizer, A, Dejager, S, Foley, J.E, Couturier, A, Ligueros-Saylan, M, Kothny, W
Published in Diabetes, obesity & metabolism (01.06.2010)
Published in Diabetes, obesity & metabolism (01.06.2010)
Get full text
Journal Article
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial
Lukashevich, V., Schweizer, A., Shao, Q., Groop, P.-H., Kothny, W.
Published in Diabetes, obesity & metabolism (01.10.2011)
Published in Diabetes, obesity & metabolism (01.10.2011)
Get full text
Journal Article
assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
Ligueros-Saylan, M, Foley, J.E, Schweizer, A, Couturier, A, Kothny, W
Published in Diabetes, obesity & metabolism (01.06.2010)
Published in Diabetes, obesity & metabolism (01.06.2010)
Get full text
Journal Article
Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials
Schweizer, A, Dejager, S, Foley, J.E, Shao, Q, Kothny, W
Published in Diabetes, obesity & metabolism (2011)
Published in Diabetes, obesity & metabolism (2011)
Get full text
Journal Article
Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial
Del Prato, S., Foley, J. E., Kothny, W., Kozlovski, P., Stumvoll, M., Paldánius, P. M., Matthews, D. R.
Published in Diabetic medicine (01.10.2014)
Published in Diabetic medicine (01.10.2014)
Get full text
Journal Article
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)
Mathieu, C., Barnett, A. H., Brath, H., Conget, I., de Castro, J. J., Göke, R., Márquez Rodriguez, E., Nilsson, P. M., Pagkalos, E., Penfornis, A., Schaper, N.C., Wangnoo, S. K., Kothny, W., Bader, G.
Published in International journal of clinical practice (Esher) (01.10.2013)
Published in International journal of clinical practice (Esher) (01.10.2013)
Get full text
Journal Article
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
Busch, S. J., Hoffmann, P., Sahota, P., Johnson, R., Kothny, W., Meyer, F., Foley, J. E.
Published in Diabetes, obesity & metabolism (01.01.2013)
Published in Diabetes, obesity & metabolism (01.01.2013)
Get full text
Journal Article
Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: A randomized 1-year study
STÖRK, S, STÖRK, C, ANGERER, P, KOTHNY, W, SCHMITT, P, WEHR, U, VON SCHACKY, C, RAMBECK, W
Published in Osteoporosis international (01.09.2000)
Published in Osteoporosis international (01.09.2000)
Get full text
Journal Article
Research: Treatment Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard-of-care metformin monotherapy—the VERIFY trial: a randomized double-blind trial
Del Prato, S, Foley, J E, Kothny, W, Kozlovski, P, Stumvoll, M, Paldánius, P M, Matthews, D R
Published in Diabetic medicine (17.07.2014)
Published in Diabetic medicine (17.07.2014)
Get full text
Journal Article
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Lukashevich, Valentina, Schweizer, Anja, Foley, James E, Dickinson, Sheila, Groop, Per-Henrik, Kothny, Wolfgang
Published in Vascular health and risk management (2013)
Published in Vascular health and risk management (2013)
Get full text
Journal Article
Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis: A Randomized, Controlled Trial
Angerer, Peter, Störk, Stefan, Kothny, Wolfgang, Schmitt, Philip, von Schacky, Clemens
Published in Arteriosclerosis, thrombosis, and vascular biology (01.02.2001)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.02.2001)
Get full text
Journal Article
Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Schweizer, Anja, Foley, James E, Kothny, Wolfgang, Ahrén, Bo
Published in Vascular health and risk management (01.01.2013)
Published in Vascular health and risk management (01.01.2013)
Get full text
Journal Article
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Schweizer, Anja, Dejager, Sylvie, Foley, James E, Kothny, Wolfgang
Published in Vascular health and risk management (01.01.2011)
Published in Vascular health and risk management (01.01.2011)
Get full text
Journal Article